Okayama, Japan

Hiroki Kakuta

USPTO Granted Patents = 7 


 

Average Co-Inventor Count = 2.2

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2013-2021

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovations by Hiroki Kakuta

Introduction

Hiroki Kakuta is a prominent inventor based in Okayama, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of drugs aimed at treating inflammatory diseases. With a total of seven patents to his name, Kakuta's work is recognized for its potential impact on healthcare.

Latest Patents

Kakuta's latest patents include a drug for preventing or treating inflammatory bowel disease. This innovative drug comprises an RXR agonist as an active ingredient, which is represented by a specific chemical formula. The formulation is designed to effectively prevent or treat inflammatory bowel disease while minimizing side effects. Another notable patent is a medicinal composition for preventing or treating inflammatory respiratory disease. This method involves administering an effective amount of an RXR agonist, also represented by a defined formula, to treat such conditions.

Career Highlights

Kakuta is affiliated with Okayama University, where he conducts research and develops his innovative solutions. His work has garnered attention for its scientific rigor and potential therapeutic benefits. His contributions to the field have positioned him as a key figure in medicinal research.

Collaborations

Kakuta collaborates with esteemed colleagues, including Hideki Matsui and Shuichi Furuya. These partnerships enhance the research environment and foster innovation within the institution.

Conclusion

Hiroki Kakuta's work exemplifies the intersection of innovation and healthcare. His patents reflect a commitment to addressing significant medical challenges through scientific research. His contributions are poised to make a lasting impact on the treatment of inflammatory diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…